Psilocybin Shows Promise in Depression Treatment, New Study Finds
Researchers from the University of Pennsylvania and Vrije University Amsterdam have conducted a comprehensive review of 15 clinical trials to assess the potential of psilocybin, a compound found in certain mushrooms, as a treatment for depression. Published in Nature Mental Health, the study combines results from trials involving 801 participants, with a focus on 12 studies comprising 585 participants. The trials compared psilocybin with other antidepressants, placebo drugs, or low doses of psilocybin. The findings suggest that psilocybin significantly reduces depression symptoms compared to other treatments. However, the researchers noted the small sample sizes and called for larger, more rigorous trials to confirm these results. 
